You are here
Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes
Kristensen PL, Tarnow L, Bay C, Nørgaard K, Jensen T, Parving HH, Perrild H, Beck-Nielsen H, Christiansen JS, Thorsteinsson B, Pedersen-Bjergaard UDiabet Med. 2017 May; 34(5): 625-631. doi: 10.1111/dme.13317. Epub 2017 Feb 14.
Editorial comment by Dr. Vivian Fonseca
Since the development of insulin analogues there has been controversy about their value....
Rawshani A, Rawshani A, Franzén S et al.N Engl J Med 2017; 376: 1407-18
Editorial Comment by Professor Kamlesh Khunti
The Swedish National Diabetes Register was set up in 1996; it has improved...
Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
Sten MadsbadJournal of Diabetes and its Complications, Volume 30, Issue 2, March 2016, Pages 374–385
Editorial comment by Sarah Cvach
Postprandial glucose (PPG) control needs to be considered when managing Diabetes.
Cardiovascular disease (CVD) is...
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: Randomized, double-blind, crossover trial
Tim Heise, Eric Zijlstra, Leszek Nosek, Tord Rikte, Hanne HaahrDiabetes, Obesity and Metabolism 2017; 19(2):208–215
Editorial Comment by Professor Thomas Pieber
Ultra-Fast insulin analogues demonstrate improved pharmacokinetic and pharmacodynamic profiles in continuous subcutaneous insulin infusion...
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects Type 1 Diabetes Mellitus
Tim Heise, Ulrike Hövelmann, Eric Zijlstra, Kirstine Stender-Petersen, Jacob Bonde Jacobsen, Hanne HaahrDrugs Aging (2017) 34: 29. doi:10.1007/s40266-016-0418-6
Editorial comment by Professor Thomas Pieber
Improved pharmacokinetic and pharmacodynamic profiles of a new ultra-fast insulin analogue in an elderly...
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective
Marc Evans, Jens Gundgaard, Brian Bekker HansenDiabetes Ther (2016) 7: 809. doi:10.1007/s13300-016-0195-6
Alissa R. Segal, Tejaswi Vootla, Richard S. BeaserEndocrinology and Metabolism Clinics of North America, Volume 45, Issue 4, December 2016, Pages 845–874
Dragana Lovre, Vivian Fonseca
Journal of Diabetes and its Complications, Volume 29, Issue 2, March 2015, Pages 295 - 301
Jeremy Dale, Steven Martin, Roger Gadsby
Primary Care Diabetes, Volume 4, Issue 2, July 2010, Pages 85 - 89
An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study
Philip Home, Nabil El Naggar, Mohammed Khamseh, Guillermo Gonzalez-Galvez, Chunduo Shen, Praful Chakkarwar, Wenying Yang
Diabetes Research and Clinical Practice, Volume 94, Issue 3, December 2011, Pages 352 - 363